Navigation Links
Infants with birthmarks received less oxygen in womb
Date:1/7/2008

Madrid, Spain January 7, 2008 A hemangioma is a benign tumor of cells that line blood vessels, appearing during the first few weeks of life as a large birthmark or lesion. A study published in Pediatric Dermatology reveals that a disturbance of oxygen depletion was found in placentas of babies who developed infantile hemangioma (IH).

Researchers reviewed placental samples from 26 pregnancies with babies who weighed less than 3.5 pounds, 13 consisting of newborns who developed IH after birth and 13 healthy preterm infants who did not have IH.

Only one of the infants without IH showed an abnormal placenta. The higher ratio of placental anomalies in babies with IH suggests that reduced oxygen to the placenta contributed to fetal stress, and that stress led to infantile hemangioma development.

Our results suggest that disturbed placental circulation is a factor underlying the development of hemangiomas in very low weight newborns and indicates that placental examination is essential for clarifying the physiologic changes leading to IH in babies with normal birth weight, the authors conclude.


'/>"/>

Contact: Amy Molnar
medicalnews@bos.blackwellpublishing.com
201-748-8844
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1

Related medicine news :

1. Nicotine in breast milk disrupts infants sleep patterns
2. Shaking may cause brain damage and serious long-term effects to infants
3. Maternal depression and controlling behavior associated with increased stress response in infants
4. Repeat steroids to premature infants linked to cerebral palsy
5. Babies raised in bilingual homes learn new words differently than infants learning one language
6. Research shows how genetic mutation causes epilepsy in infants
7. Combination vaccines okay for infants, study shows
8. $4 million nursing grant focuses on at-risk premature infants
9. McNeil Consumer Healthcare is Voluntarily Withdrawing Infants Cough and Cold Products:
10. Drug Makers Withdraw Cough, Cold Meds for Infants
11. Dr. Laura Jana Offers Parents Five Key Ways to Ensure Accurate Dosing of Liquid Medication to Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: